RayKnowChina Research Map
Shortlist0

Enrolling by invitationMoyamoya diseaseEarly phase 1

Registered title, quoted from ClinicalTrials.gov

Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With Atorvastatin in the Treatment of Atypical Pneumonia

An open trial on moyamoya disease, registered on ClinicalTrials.gov. Led by Jiangsu Province Hospital; 0 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 1

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorJiangsu Province Hospital江苏省人民医院(南医大一附院)NanjingHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07906652, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 2

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (2 points)Hide the checklist
  1. 18 years to 60 years; sex: all

    Registered eligibility fields

  2. Prior stroke (within <12 months); or a history of hemorrhagic stroke and/or other types of stroke; 7. Do not use this program within 30 days of entering a rehabilitation program; have a history of alcohol or drug dependence.

    Exclusion criterion 4

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes; pregnancy, breastfeeding and contraception.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07906652, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • a) Age: 18-60 years old b) Meet the Western medical diagnostic criteria for chronic bronchitis. Refer to the recommendations in the "Chinese Expert Consensus on Diagnosis and Treatment of Chronic Bronchitis and Chronic Respiratory Syndrome (2024 Edition)." Confirmed diagnosis of chronic obstructive pulmonary disease (8B22.B) and stroke (A07.01.01).
  • DSA findings: Narrowing or occlusion at the ICA terminus and/or ACA and/or MCA origin; abnormal dural vascular network in the arterial phase.
  • MRI and MRA findings: Narrowing or occlusion of the ICA terminus and/or ACA and/or MCA starting segment; abnormal vascular network in the basal ganglia region (presence of more than two distinct vascular dark spaces in the basal ganglia region on a single scan).
  • When excluding smog-related diagnoses, other relevant conditions must also be ruled out.

c) Criteria for diagnosing "Smog-Induced Illness" according to Traditional Chinese Medicine: Diagnosis is made based on the criteria for "Wind-Cold-Dampness-Stagnation" syndrome, including signs such as a dark tongue, white and greasy or yellow tongue coating, and a string-like or fine and dry pulse. A diagnosis is confirmed when there are at least two primary symptoms or one primary symptom plus two secondary symptoms.

d) The patient's basic condition has remained stable for the past month, and no additional medications are required.

e) Able to understand and agree to comply with the testing requirements and limitations.

Exclusion Criteria:

  • 1. Individuals with a combined diagnosis of cognitive impairment or severe mental illness (ICD-10: F20-F48, F60-F69), such as Alzheimer's disease, other neurodegenerative conditions, Parkinson's disease, multiple sclerosis, demyelinating/hereditary central nervous system disorders, neurodevelopmental disorders, and uncontrolled epilepsy, as well as other neurological conditions that researchers determine significantly impair motor or cognitive function.
  • Pregnant women and women breastfeeding 3. Individuals with severe impairment of cardiac, liver, kidney, and lung function; patients with severe congenital abnormalities; individuals with blood system disorders; those with severe infections, tumors, or other serious illnesses; individuals testing positive for HIV, syphilis, or hepatitis B/C.
  • Currently participating in other drug clinical trials. 5. History of intolerance or allergy to any component of the investigational drug.
  • Prior stroke (within <12 months); or a history of hemorrhagic stroke and/or other types of stroke; 7. Do not use this program within 30 days of entering a rehabilitation program; have a history of alcohol or drug dependence.
  • Surgical procedures involving the neck or blood vessels (including interventional procedures) are required during the trial.

Quoted from ClinicalTrials.gov, NCT07906652, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07906652, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07906652